The global Cerebral Angiography market is estimated to be valued at US$ 14.96 billion in 2023 and is expected to exhibit a CAGR of 6.1% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Cerebral angiography is a diagnostic imaging technique used to visualize the blood vessels in the brain and detect any abnormalities or diseases. It involves the injection of a contrast dye into the blood vessels, followed by X-ray imaging. This procedure helps in diagnosing conditions such as aneurysms, arteriovenous malformations, and strokes.

Cerebral angiography has become an essential tool in neurology and neurosurgery, allowing for accurate diagnosis and treatment planning. With the advancement in technology, there has been a shift towards minimally invasive procedures, which has further boosted the demand for cerebral angiography.

Market Dynamics:
1. Technological Advancements: Cerebral Angiography Market Size is driven by continuous technological advancements. Innovations such as digital subtraction angiography (DSA), rotational angiography, and 3D angiography have improved the quality of imaging and reduced radiation exposure for patients. These advancements have made cerebral angiography a safer and more effective diagnostic tool.

2. Growing Demand for Minimally Invasive Procedures: There is a rising demand for minimally invasive procedures, as they offer several advantages over traditional open surgeries, such as shorter hospital stays, lower risk of complications, and faster recovery. Cerebral angiography can be performed as a minimally invasive procedure, using a catheter inserted through a small incision in the groin or wrist. This has led to increased adoption of cerebral angiography, driving market growth.

Segment Analysis:
The cerebral angiography market can be segmented based on procedure type, application, end-user, and region. Among the procedure type, the diagnostic angiography segment dominated the market in 2022, as it is widely used for the diagnosis of various neurovascular diseases. In terms of application, the neurology segment held the largest market share, owing to the high prevalence of neurovascular diseases. Hospitals and diagnostic centers are the major end-users of cerebral angiography.

PEST Analysis:
- Political: The implementation of favorable government regulations and policies for healthcare infrastructure development and reimbursement policies can positively impact the growth of the cerebral angiography market.
- Economic: The increasing healthcare expenditure and reimbursement options in developed and developing countries contribute to the growth of the market.
- Social: The rising prevalence of neurovascular diseases and the aging population are key social factors driving market growth.
- Technological: Continuous technological advancements, such as hybrid angiography systems and robotic-assisted angiography, are expected to drive market growth.

Key Takeaways:
- The global cerebral angiography market is expected to witness high growth, exhibiting a CAGR of 6.1% over the forecast period, due to increasing technological advancements and growing demand for minimally invasive procedures.
- North America is the dominating region in the global cerebral angiography market, driven by well-established healthcare infrastructure, high adoption of advanced medical technologies, and increasing prevalence of neurovascular diseases.
- Key players operating in the global cerebral angiography market include Siemens Healthineers AG, GE Healthcare, Koninklijke Philips N.V., Canon Medical Systems Corporation, Shimadzu Corporation, Hitachi, Ltd., Carestream Health, Inc., Medtronic plc, Stryker Corporation, Terumo Corporation, Boston Scientific Corporation, AngioDynamics, Inc., Penumbra, Inc., MicroPort Scientific Corporation, and Cook Medical LLC. These players focus on technological advancements, mergers and acquisitions, and collaborations to strengthen their market position.

In conclusion, the global cerebral angiography market is expected to grow significantly over the forecast period, driven by technological advancements and increasing demand for minimally invasive procedures. North America is likely to dominate the market due to its well-established healthcare infrastructure. Key market players continue to invest in research and development activities to introduce innovative products and maintain their competitive edge.